GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 15 filers reported holding GAIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,264 | +19.0% | 1,300 | +62.5% | 0.00% | – |
| Q2 2023 | $3,584 | -7.1% | 800 | 0.0% | 0.00% | – |
| Q1 2023 | $3,856 | +54.0% | 800 | 0.0% | 0.00% | – |
| Q4 2022 | $2,504 | -37.4% | 800 | -24.0% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 1,052 | +31.5% | 0.00% | – |
| Q2 2022 | $3,000 | 0.0% | 800 | -0.4% | 0.00% | – |
| Q1 2022 | $3,000 | -25.0% | 803 | +0.4% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -25.0% | 800 | 0.0% | 0.00% | – |
| Q2 2021 | $8,000 | -33.3% | 800 | 0.0% | 0.00% | – |
| Q1 2021 | $12,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 151,132 | $807,000 | 1.04% |
| CM Management, LLC | 90,000 | $489,000 | 0.37% |
| Greenlight Capital | 546,560 | $2,968,000 | 0.17% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $315,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 50,000 | $267,000 | 0.01% |
| Veritable, L.P. | 25,064 | $136,000 | 0.00% |
| Banque Cantonale Vaudoise | 3,000 | $16,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 20,056 | $107,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 15,754 | $84,000 | 0.00% |
| MORGAN STANLEY | 800 | $4,000 | 0.00% |